Chaowei Ren
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
-
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
-
- Protein Degradation and Inhibitors 9
- Ubiquitin and proteasome pathways 7
-
- Multiple Myeloma Research and Treatments 6
- Co-authors
- Xiaobao Yang (9 shared papers)Biao Jiang (9 shared papers)Renhong Sun (5 shared papers)Jinju Chen (5 shared papers)Ning Sun (4 shared papers)Xing Qiu (5 shared papers)Qianqian Yin (4 shared papers)Ying Kong (3 shared papers)
- Journals
- European Journal of Medicinal Chemistry (5 papers)Journal of Medicinal Chemistry (2 papers)Chemical Communications (1 paper)Organic & Biomolecular Chemistry (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Chaowei Ren
9 papers receiving 380 citations
Peers
Comparison fields: 5 of 23
- Hematology 168
- Oncology 188
- Molecular Biology 358
- Genetics 10
- Organic Chemistry 25
Countries citing papers authored by Chaowei Ren
This map shows the geographic impact of Chaowei Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaowei Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaowei Ren more than expected).
Fields of papers citing papers by Chaowei Ren
This network shows the impact of papers produced by Chaowei Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaowei Ren. The network helps show where Chaowei Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Chaowei Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 104 | |
| 2 | 2020 | 66 | |
| 3 | 2022 | 50 | |
| 4 | 2021 | 42 | |
| 5 | 2021 | 38 | |
| 6 | 2021 | 32 | |
| 7 | 2020 | 24 | |
| 8 | 2022 | 23 | |
| 9 | 2022 | 3 |
About Chaowei Ren
Chaowei Ren is a scholar working on Molecular Biology, Hematology, Oncology, Infectious Diseases and Organic Chemistry, having authored 9 papers that have together received 382 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (9 papers), Ubiquitin and proteasome pathways (7 papers), Multiple Myeloma Research and Treatments (6 papers), Peptidase Inhibition and Analysis (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Hematology (168 citations), Oncology (188 citations), Molecular Biology (358 citations), Genetics (10 citations) and Organic Chemistry (25 citations). Chaowei Ren has collaborated with scholars based in China and United States. Frequent co-authors include Xiaobao Yang, Biao Jiang, Renhong Sun, Jinju Chen, Ning Sun, Xing Qiu, Qianqian Yin, Ying Kong, Haixia Liu and Hui Zhong. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, Chemical Communications and Organic & Biomolecular Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.